INFLUENCE OF LOCALLY APPLIED HEAT ON THE PERFORMANCE OF TRANSDERMAL DICLOFENAC SODIUM PLASTERS
Objective: Applied heat to dermatologic preparations influences the medicine's performance, such as drug release rate and drug absorption. However, there is little information concerning the performance of non-steroid anti-inflammatory drug plasters at high temperature. Therefore, this study aimed to evaluate the effect of heat on drug dissolution and skin permeation from two kinds of Diclofenac sodium (DF) plasters In vitro, as well as transdermal absorption in healthy adult volunteers.
Methods: DF dissolution tests were performed using the paddle-over-disk method with 500 mL of phosphate-buffered saline at 32 and 41Â°C. DF permeation was studied at 32 and 41Â°C using a Franz-type cell with Yucatan micropig skin (YMP). Moreover, eight healthy volunteers were tested two times for each preparation while receiving a piece of DF plaster, and then the same plaster with a heat-generating pad over 4 hours maintained at 40-41Â°C; then, the residual amount of DF in the plasters was evaluated.
Results: Significant differences in the cumulative amount released from the preparations were seen between 32 and 41Â°C. The cumulative amount that permeated across YMP skin from all preparations at 32Â°Cwas also significantly higher than that obtained at 41Â°C. Furthermore, heat application on the plasters resulted in 1.4-fold higher absorption amount than without heat in the clinical study.
Conclusion: This study indicated that locally applied heat caused rapid and substantial drug release, resulting in increased transdermal absorption of DF compared with that upon the use of the plaster without heat.
2. Chui MA, Stone JA, Martin BA, Croes KD, Thorpe JM. Safeguarding older adults from inappropriate over-the-counter medications: the role of community pharmacists. Gerontologist 2013;doi: 10.1093/geront/gnt130.
3. Shomaker TS, Zhang J, Ashburn MA. Assessing the impact of heat on the systemic delivery of fentanyl through the transdermal fentanyl delivery system. Pain Med 2000;1:225-30.
4. Ashburn MA, Ogden LL, Zhang J, Love G, Basta SV. The pharmacokinetics of transdermal fentanyl delivered with and without controlled heat. J Pain 2003;4:291-7.
5. Shomaker TS, Zhang J, Ashburn MA. A pilot study assessing the impact of heat on the transdermal delivery of testosterone. J Clin Pharmacol 2001;41:677-82.
6. Klemsdal TO, Gjesdal K, Bredesen JE. Heating and cooling of the nitroglycerin patch application area modify the plasma level of nitroglycerin. Eur J Clin Pharmacol 1992;43:625-8.
7. FrÃ¶lich MA, Giannotti A, Modell JH. Opioid overdose in a patient using a fentanyl patch during treatment with a warming blanket. Anesth Analg 2001;93(3):647-8.
8. Roth JV. Warming blankets should not be placed over transdermal medications. Anesth Analg 2002;94(4):1043.
9. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract 2004;5:10.
10. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord 2004;5:28.
11. Awa K, Satoh H, Hori S, Sawada Y. Prediction of systemic exposure of ketoprofen tapes by In vitro test and pharmacokinetic model analysis: comparison between brand-name and generic formulations. Yakugaku Zasshi 2012;132(1):135-44.
12. The United States Pharmacopeial Convention. The United States pharmacopeia, 30th ed. Rockville; 2007.
13. Arellano A, Santoyo S, MartÃn C, Ygartua P. Enhancing effect of terpenes on the In vitro percutaneous absorption of diclofenac sodium. Int J Pharm 1996;130:141-5.
14. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 1961;50:874-5.
15. Caon T, Costa AC, de Oliveira MA, Micke GA, SimÃµes CM. Evaluation of the transdermal permeation of different paraben combinations through a pig ear skin model. Int J Pharm 2010;391(1-2):1-6.
16. Melero A, Garrigues TM, Almudever P, Villodre AM, Lehr CM, SchÃ¤fer U. Nortriptyline hydrochloride skin absorption: development of a transdermal patch. Eur J Pharm Biopharm 2008;69(2):588-96.
17. Otto DP, de Villiers MM. The experimental evaluation and molecular dynamics simulation of a heat-enhanced transdermal delivery system. AAPS Pharm Sci Tech 2013;14(1):111-20.
18. Package insert of Voltalen AC tape. Novartis Pharm Co; 2013.
19. Package insert of Fatas Z tape. Hisamitsu Pharm Co; 2013.
20. Fujii M, Yamanouchi S, Hori N, Iwanaga N, Kawaguchi N, Matsumoto M. Evaluation of Yucatan micropig skin for use as an In vitro model for skin permeation study. Biol Pharm Bull 1997;20(3):249-54.
21. Obata Y, Utsumi S, Watanabe H, Suda M, Tokudome Y, Otsuka M, et al. Infrared spectroscopic study of lipid interaction in stratum corneum treated with transdermal absorption enhancers. Int J Pharm 2010;389(1-2):18-23.
22. Ohtani M, Matsumoto M, Namiki M, Yamanura Y, Sugiura M, Uchino K. Evaluation of pharmaceutical equivalency between genuine and generic ketoprofen tape. J Pharm Sci Tech Jpn 2011;71(2):120-5.
23. Watanabe T, Satoh H, Hori S, Miki A, Ohtani H, Sawada Y. Model analysis of tulobuterol patch formulations to explain the influence of drug release rate and transdermal transfer rate on the plasma concentration profile. Yakugaku Zasshi 2011;131(10):1483-92.